Try a synonym, or sign up to suggest a template from the app.
BioRender Template
Drugs Targeting TGF-β Induced Plasticity
Description
Three therapeutic mechanisms for inhibiting the TGF-β pathway in cancer: Galunisertib inhibits TGFβ-RI kinase activity, preventing Smad2/3 activation. It has been combined with sorafenib, radiation, gemcitabine, and temozolomide. Fresolimumab acts as a TGF-β trap by competitively binding TGF-β and has been combined with radiation in clinical trials. Bintrafusp-alfa is a first-in-class dual inhibitor of PD-L1 and TGF-β. Adapted from Fig. 7, Proactive and reactive roles of TGF-β in cancer.
Use this templateThis template is fully editable in BioRender with a free BioRender account — no credit card required to sign up.
Don’t start from scratch.
Create professional scientific illustrations quickly and easily, even without any design expertise
- Get started with a huge library of editable icons and templates such as common biological pathways, anatomy, or genetics.
- Create figures that effectively communicate your research in half the time using our editable icons.
- Use our PDB tool to quickly generate and customize protein structures.
.gif)




